Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third ...

Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing ...

We’ve uncovered a list of what we consider to be five recession-proof dividend stocks yielding over 6%, much higher than the ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

Pfizer Declares Third-Quarter 2025 Dividend. Board of Directors approves quarterly cash dividend of $0.43 per share. Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a ...

Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential ...

That said, Pfizer Inc. (NYSE:PFE) has a five-year average payout ratio above 101%, which may seem alarming at first. A company can’t consistently pay more in dividends than it earns.

Pfizer has recently been actively involved in oncology and ... With a market cap of approximately $425 billion and a robust dividend history, this stock is perfect for conservative investors. With ...

Importantly, Pfizer Inc. (NYSE:PFE) does carry debt. But is this debt a concern to shareholders? We've found 21 US stocks ...

The Schwab U.S. Dividend Equity ETF yields around 4% today, which means that it would take an investment of approximately $50 ...

Barron’s has long favored dividend-paying stocks for those seeking income. But bonds now deserve a hard look because they are ...

The dividend record date is when a company finalises eligible shareholders for dividend, e.g., if a company sets June 27, ...